A comparison of complementary measures of vitamin B6 status, function, and metabolism in the European Prospective Investigation into Cancer and Nutrition (EPIC) study.
PLP
dietary biomarkers
kynurenine pathway
transsulfuration pathway
vitamin B6
Journal
The American journal of clinical nutrition
ISSN: 1938-3207
Titre abrégé: Am J Clin Nutr
Pays: United States
ID NLM: 0376027
Informations de publication
Date de publication:
01 07 2021
01 07 2021
Historique:
received:
23
10
2020
accepted:
08
02
2021
pubmed:
9
4
2021
medline:
8
9
2021
entrez:
8
4
2021
Statut:
ppublish
Résumé
Vitamin B6 insufficiency has been linked to increased risk of cancer and other chronic diseases. The circulating concentration of pyridoxal 5'-phosphate (PLP) is a commonly used measure of vitamin B6 status. Ratios of substrates indicating PLP coenzymatic function and metabolism may be useful complementary measures to further explore the role of vitamin B6 in health. We explored the sensitivity of 5 outcomes, namely PLP concentration, homocysteine:cysteine (Hcy:Cys), cystathionine:cysteine (Cysta:Cys), the 3´-hydroxykynurenine ratio (HKr), and the 4-pyridoxic acid ratio (PAr) to vitamin B6 intake as well as personal and lifestyle characteristics. Dietary intake and biomarker data were collected from participants from 3 nested case-control studies within the European Prospective Investigation into Cancer and Nutrition (EPIC). Bayesian regression models assessed the associations of the 5 biomarker outcomes with vitamin B6 intake and personal and lifestyle covariates. Analogous models examined the relations of Hcy:Cys, Cysta:Cys, and HKr with PLP. In total, 4608 participants were included in the analyses. Vitamin B6 intake was most strongly associated with PLP, moderately associated with Hcy:Cys, Cysta:Cys, and HKr, and not associated with PAr (fold change in marker given a doubling of vitamin B6 intake: PLP 1.60 [95% credible interval (CrI): 1.50, 1.71]; Hcy:Cys 0.87 [95% CrI: 0.84, 0.90]; Cysta:Cys 0.89 [95% CrI: 0.84, 0.94]; HKr 0.88 [95% CrI: 0.85, 0.91]; PAr 1.00 [95% CrI: 0.95, 1.05]). PAr was most sensitive to age, and HKr was least sensitive to BMI and alcohol intake. Sex and menopause status were strongly associated with all 5 markers. We found that 5 different markers, capturing different aspects of vitamin B6-related biological processes, varied in their associations with vitamin B6 intake and personal and lifestyle predictors.
Sections du résumé
BACKGROUND
Vitamin B6 insufficiency has been linked to increased risk of cancer and other chronic diseases. The circulating concentration of pyridoxal 5'-phosphate (PLP) is a commonly used measure of vitamin B6 status. Ratios of substrates indicating PLP coenzymatic function and metabolism may be useful complementary measures to further explore the role of vitamin B6 in health.
OBJECTIVES
We explored the sensitivity of 5 outcomes, namely PLP concentration, homocysteine:cysteine (Hcy:Cys), cystathionine:cysteine (Cysta:Cys), the 3´-hydroxykynurenine ratio (HKr), and the 4-pyridoxic acid ratio (PAr) to vitamin B6 intake as well as personal and lifestyle characteristics.
MEDTHODS
Dietary intake and biomarker data were collected from participants from 3 nested case-control studies within the European Prospective Investigation into Cancer and Nutrition (EPIC). Bayesian regression models assessed the associations of the 5 biomarker outcomes with vitamin B6 intake and personal and lifestyle covariates. Analogous models examined the relations of Hcy:Cys, Cysta:Cys, and HKr with PLP.
RESULTS
In total, 4608 participants were included in the analyses. Vitamin B6 intake was most strongly associated with PLP, moderately associated with Hcy:Cys, Cysta:Cys, and HKr, and not associated with PAr (fold change in marker given a doubling of vitamin B6 intake: PLP 1.60 [95% credible interval (CrI): 1.50, 1.71]; Hcy:Cys 0.87 [95% CrI: 0.84, 0.90]; Cysta:Cys 0.89 [95% CrI: 0.84, 0.94]; HKr 0.88 [95% CrI: 0.85, 0.91]; PAr 1.00 [95% CrI: 0.95, 1.05]). PAr was most sensitive to age, and HKr was least sensitive to BMI and alcohol intake. Sex and menopause status were strongly associated with all 5 markers.
CONCLUSIONS
We found that 5 different markers, capturing different aspects of vitamin B6-related biological processes, varied in their associations with vitamin B6 intake and personal and lifestyle predictors.
Identifiants
pubmed: 33829249
pii: S0002-9165(22)00334-3
doi: 10.1093/ajcn/nqab045
pmc: PMC8246608
doi:
Substances chimiques
Vitamin B 6
8059-24-3
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
338-347Subventions
Organisme : Cancer Research UK
ID : 24390
Pays : United Kingdom
Organisme : Cancer Research UK
ID : 25004
Pays : United Kingdom
Organisme : Medical Research Council
ID : 1000143
Pays : United Kingdom
Informations de copyright
© The Author(s) 2021. Published by Oxford University Press on behalf of the American Society for Nutrition.
Références
Eur J Clin Nutr. 2009 Nov;63 Suppl 4:S122-49
pubmed: 19888270
J Nutr. 2013 Jun;143(6):957S-65S
pubmed: 23576641
J Natl Cancer Inst. 2014 Nov 05;106(12):
pubmed: 25376861
Am J Clin Nutr. 2020 Jan 1;111(1):178-186
pubmed: 31557280
Anal Chem. 2016 Nov 1;88(21):10427-10436
pubmed: 27715010
Eur J Clin Nutr. 2009 Nov;63 Suppl 4:S226-38
pubmed: 19888276
Int J Epidemiol. 1997;26 Suppl 1:S6-14
pubmed: 9126529
Nutrients. 2017 Jan 10;9(1):
pubmed: 28075382
Int J Cancer. 2015 Feb 15;136(4):915-27
pubmed: 24975698
BMC Syst Biol. 2018 Oct 24;12(1):89
pubmed: 30355281
J Am Diet Assoc. 2010 Nov;110(11):1660-8
pubmed: 21034879
Br J Nutr. 2013 Jul 28;110(2):363-74
pubmed: 23228223
Rapid Commun Mass Spectrom. 2009 May;23(9):1371-9
pubmed: 19337982
Am J Clin Nutr. 2008 May;87(5):1446-54
pubmed: 18469270
Eur J Clin Nutr. 2010 Aug;64(8):905-13
pubmed: 20502473
J Gerontol A Biol Sci Med Sci. 2020 Jan 20;75(2):374-379
pubmed: 30657862
J Clin Pathol. 1991 Jul;44(7):592-5
pubmed: 1856292
J Gerontol A Biol Sci Med Sci. 1996 Nov;51(6):B417-24
pubmed: 8914491
Annu Rev Nutr. 1999;19:217-46
pubmed: 10448523
Int J Epidemiol. 1997;26 Suppl 1:S1-5
pubmed: 9126528
JAMA. 2010 Jun 16;303(23):2377-85
pubmed: 20551408
J Nutr. 2009 Apr;139(4):784-91
pubmed: 19244383
Nutrients. 2016 Sep 01;8(9):
pubmed: 27598193
Annu Rev Nutr. 2015;35:33-70
pubmed: 25974692
Methods Enzymol. 1997;281:43-53
pubmed: 9250965
Sci Rep. 2017 Dec 14;7(1):17559
pubmed: 29242525
Am J Clin Nutr. 2014 Jul;100(1):250-5
pubmed: 24808485
Eur J Clin Nutr. 2007 Sep;61(9):1037-56
pubmed: 17375121
PLoS One. 2018 May 7;13(5):e0196465
pubmed: 29734388
Crit Rev Food Sci Nutr. 2019;59(16):2697-2707
pubmed: 30431328
Annu Rev Public Health. 2016;37:17-32
pubmed: 26653405
J Nutr. 2017 Jun;147(6):1167-1173
pubmed: 28381531
J Exp Bot. 2005 Jan;56(410):267-72
pubmed: 15545297
Public Health Nutr. 2002 Dec;5(6B):1113-24
pubmed: 12639222
Clin Chem. 2005 Nov;51(11):2103-9
pubmed: 16123148
Am J Clin Nutr. 2018 Sep 1;108(3):611-621
pubmed: 30101351
Clin Chem. 2010 May;56(5):755-63
pubmed: 20299681
J Hepatol. 2010 Sep;53(3):551-7
pubmed: 20561703
Int J Cancer. 2019 Mar 1;144(5):947-956
pubmed: 29786139
Cancer Res. 2018 Jan 1;78(1):302-308
pubmed: 29070616
J Natl Cancer Inst. 2017 Mar 1;109(3):1-9
pubmed: 28376200
Int J Cancer. 2015 Jun 15;136(12):2932-9
pubmed: 25404109